Genetic susceptibility and gastric cancer risk

International Journal of Cancer

Volumn 100, Issue 3, 2002, Pages 249-260

  González, Carlos A ^a,c   Sala, Nüria ^b   Capellá, Gabriel ^a  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b Research Institute   (Spain)

^c NONE   (Spain)

Author keywords

Gastric cancer; Genetic susceptibility; Review

Indexed keywords

CYTOCHROME P450 2E1; HLA DQ ANTIGEN; TUMOR NECROSIS FACTOR;

CANCER GENETICS; CANCER RESEARCH; CANCER RISK; CANCER SUSCEPTIBILITY; DIET; DNA POLYMORPHISM; DNA REPAIR; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HLA SYSTEM; HUMAN; MEDICAL LITERATURE; MEDLINE; PRIORITY JOURNAL; PUBLICATION; SHORT SURVEY; SMOKING; STOMACH CANCER;

CA-15-3 ANTIGEN; CARCINOGENS; DNA DAMAGE; GASTRIC MUCOSA; GENES, MHC CLASS I; GENES, MHC CLASS II; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-1; ONCOGENES; RISK; STOMACH NEOPLASMS;

EID: 0037143090     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10466     Document Type: Short Survey

References (93)

1. Eucan database
2. Is Helicobacter pylori infection a cause of gastric neoplasia?
3. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations
4. Tobacco smoking and gastric cancer: Review and meta-analysis
5. Molecular epidemiology: Recent advances and future directions
6. Cancer prevention and diet: Help from single nucleoide polymorphisms
7. Metabolic susceptibility genes as cancer risk factors: Time for a reassessment?
8. Gastric cancer and H. pylori: Host genetics open the way
9. Genetic alterations in human gastric cancer
10. Molecular biology and gastric carcinoma
11. Phenotypic and genotypic events in gastric carcinogenesis
12. Genetic alterations in human gastrointestinal cancers
13. Recomendations for a nomenclature system for human gene mutations
14. Metabolic gene allele nomenclature
15. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression
16. MUC1 gene polymorphism and gastric cancer - An epidemiological study
17. MUC1 gene polymorphism does not explain the different incidence of gastric cancer in Portugal and Denmark
18. MUC6 gene polymorphism in healthy individuals and in gastric cancer patients from northern Portugal
19. Gastric carcinoma exhibits distinct types of cell differentiation: An immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6)
20. The trefoil peptide family
21. DNA hypermethylation at the pS2 promoter region is associated with early stage of stomach carcinogenesis
22. Variable distribution of TFF2 (spasmolysin) alleles in Europeans does not indicate predisposition to gastric cancer
23. B in Helicobacter pylori associated disease
24. Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways
25. In vitro production of IL 1 beta, IL 1 alpha, TNF and IL2 in healthy subjects: Distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation
26. Interleukin-1 polymorphisms associated with increased risk of gastric cancer
27. Interleukin 1B and intrerleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma
28. Association of gastric adenocarcinoma with the HLA class II gene DQB1*0301
29. DNA typing of HLA class I (HLA-A) and class II genes (HLA-DR,-DQ and -DP) in Japanese patients with gastric cancer
30. The role of HLA-DQA1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by Helicobacter pylori infection
31. Gastric cancer and human leukocyte antigen: Distinct DQ and DR alleles are associated with development of gastric cancer and infection by Helicobacter pylori
32. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection
33. Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production
34. The -238 tumor necrosis factor-α promoter polymorfism is associated with decreased susceptibility to cancer
35. Cyclooxygenase-2 and carcinogenesis
36. Effects of NSAIDs on proliferation of gastric cancer cells in vitro: Possible implication of cyclooxygenase-2 in cancer development
37. Cyclooxigenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions
38. Increased expression of cyclooxygenase-2 protein in human gastric carcinoma
39. Expression of cyclooxygenate-2 in dysplasia of the stomach and in intestinal-type gastric adenocarcinoma
40. Expression of cyclooxigenase-2 in human adenocarcinomas of the gastric cardia and corpus
41. Effect of anti-inflamatory drugs on overall risk of common cancer: Case-control study in general practice research database
42. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer
43. Aspirin protects against gastric cancer: Results of a case-control study from Moscow, Russia
44. Mutagenic activation of environmental carcinogenesis by microsomes of gastric mucosa with intestinal metaplasia
45. Expression of cytochrome P450 3A4 in foveolar epithelium with intestinal metaplasia of the human stomach
46. Enhaced expression of cytochrome P450 in stomach cancer
47. Genetic linkage of lung cancer-associated Msp1 polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene
48. Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene
49. A Taq 1 polymorphism in the human P450IIE1 gene on chromosome 10(CYP2E)
50. Cytochrome P4502E1 (CYP2E1) genetic polymorphism in a case-control study of gastric cancer and liver disease
51. Genetic polymorphisms of the cancer related gene and Helicobacter pylori infection in japanese gastric cancer patients
52. Helicobacter pylori infection and genetic polymorphisms for cancer-related genes in gastric carcinogenesis
53. Cytochrome P450 2E1 polymorphism in gastric cancer in Brazil: Case-control studies of Japanese Brazilians and non-Japanese Brazilians
54. The Cyp2 subfamily: Function, Expression and Genetic polymorphism
55. Metabolic gene polymorphism frequencies in control populations
56. The human glutathione S-transferase: A case-control study of the incidence of the GST1 O phenotype in patients with adenocarcinoma
57. Detection of GSTI gene deletion by the polymerase chain reaction and its possible correlation with stomach cancer in Japanese
58. Glutathione S-tranferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma
59. Glutathione S-transferase M1 and T1 null genotypes and the risk of gastric and colorectal cancers
60. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: Studies of interactions with GSTMI in lung, oral, gastric and colorectal cancers
61. GSTT1 and GSTM1 null genotypes and the risk of gastric cancer: A case-control study in a Chinese population
62. Glutathione S-transferase genotypes and stomach cancer in population-based case-control study in Warsaw, Poland
63. Human glutathione S-transferase P1 polymorphism and susceptibility to smoking related epithelial cancer; oral, lung, gastric, colorectal and urothelial cancer
64. GSTP1 polymorphisms and gastric cancer in high-risk Chinese population
65. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation
66. Inherited polymorphism in the N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and susceptibility to gastric and colorectal adenocarcinoma
67. A pilot study investigating the role of NATI and NAT2 polymorphisms in gastric adenocarcinoma
68. Helicobacterpylori causes DNA damage in gastric epithelial cells
69. Helicobacterpylori eradication attenuates oxidative stress in human gastric mucosa
70. Inducible nitric oxide synthase, anti-oxidant enzymes and Helicobacter pylori infection in gastritis and gastric precancerous lesions in humans
71. Nutritional factors and gastric cancer in Spain
72. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: A case-control study
73. Methylenetetrahydrofolate reductase polymorphisms, folate, and cancer risk: A paradigm of gene-nutrient interactions in carcinogenesis
74. Markers of DNA repair and susceptibility to cancer in humans; an epidemiologic review
75. Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population
76. A polymorphism at codon 160 of human O6-methylguanine-DNA methyltransferase gene in young patients with adult type cancers and functional assay
77. Infrequent mutations of the hOGGI gene, that is involved in the excision of 8-hydroxyguanine in damaged DNA, in human gastric cancer
78. hOGG1 exon7 polymorphism and gastric cancer in case-control studies of Japanese Brazilians and non-Japanese Brazilians
79. Microsatellite instability
80. Red meat, family history, and increased risk of gastric cancer with microsatellite instability
81. Correlation of L-myc genotypes to metastasis of gastric cancer and breast cancer
82. Association between restriction fragment length polymorphism of the L-myc gene and the susceptibility to gastric cancer
83. Overexpression of p53 in different subtypes of intestinal metaplasia and gastric cancer
84. p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type
85. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas
86. The use of common genetic polymorphisms to enhance the epidemiologic study of environmental carcinogens
87. Power and sample size calculations in case-control studies of gene-environment interactions: Comments on different approaches
88. Population stratification in epidemiologic studies of common genetic variants and cancer: Quantification of bias
89. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten countries
90. Gastric cancer and Helicobacter pylori: A combined analysis of 12 case control studies nested within prospective cohorts
91. Cancer - Nature, nurture, or both